U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
Trump or Biden? The Stock Market Doesn’t Care.

Trump or Biden? The Stock Market Doesn’t Care.

Prediction markets say former President Donald J. Trump has a good chance of winning. So far, the stock market is fine with that.